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I N T R O D U C T I O N
Large-conductance Ca
2+-activated K
+ (BKCa) channels are 
expressed in a wide variety of cell types and consist of 
pore-forming  subunits and auxiliary 1–4 subunits that 
modify channel function (Lu et al., 2006). In arterial 
smooth muscle cells, 1 subunits are the principal mo-
lecular  and  functional  BKCa  channel  auxiliary  subunit 
isoform (Brenner et al., 2000; Plüger et al., 2000). Arte-
rial smooth muscle cell BKCa channel activation causes 
membrane hyperpolarization, leading to a reduction in 
voltage-dependent Ca
2+ channel activity, a decrease in in-
tracellular Ca
2+ concentration ([Ca
2+]i), and vasodilation 
(Davis and Hill, 1999; Jaggar et al., 2000). In contrast, 
BKCa channel inhibition causes membrane depolariza-
tion, which activates voltage-dependent Ca
2+ channels, 
leading to an [Ca
2+]i elevation and vasoconstriction.
Global cytosolic [Ca
2+]i is typically 100–300 nM, whereas 
BKCa channels are sensitive to micromolar [Ca
2+]i (Jaggar 
et al., 2000; Pérez et al., 2001). In arterial smooth muscle 
cells, BKCa channels are activated by localized micromolar 
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Abbreviations  used  in  this  paper:  BKCa,  large-conductance  Ca
2+- 
activated K
+; [Ca2+]i, intracellular Ca
2+ concentration; coIP, coimmuno-
precipitation;  immuno-FRET,  immunofluorescence  resonance  energy 
transfer; IP3, 1,4,5-trisphosphate; [IP3]i, intracellular IP3 concentration; 
IP3R, IP3 receptor.
[Ca
2+]i transients termed Ca
2+ sparks (Nelson et al., 1995; 
Jaggar et al., 2000). Ca
2+ sparks are generated by the con-
certed opening of several SR ryanodine-sensitive Ca
2+ re-
lease (RYR) channels (Nelson et al., 1995; Jaggar et al., 
2000). Ca
2+ spark–induced BKCa currents induce mem-
brane hyperpolarization and vasodilation.
SR  inositol  1,4,5-trisphosphate  (IP3)-gated  Ca
2+  re-
lease channels are also expressed in many different cell 
types, including arterial smooth muscle (Thrower et al., 
2001; Morel et al., 2003; Foskett et al., 2007; Zhao et al., 
2008; Zhou et al., 2008). In native and cultured vascular 
smooth muscle cells, IP3 receptor (IP3R) activation stim-
ulates propagating intracellular Ca
2+ waves and elevates 
global [Ca
2+]i (Lee et al., 2002; Lamont and Wier, 2004; 
Wilkerson et al., 2006; Zhao et al., 2008). Three different 
IP3R isoforms (1–3) have been identified, each of which 
is encoded by a different gene (Ross et al., 1992; Blondel 
et al., 1993). Type 1 IP3Rs are the principal molecular 
and functional IP3R isoform mediating agonist and IP3-
induced intracellular Ca
2+ signals in aortic and cerebral 
artery smooth muscle cells (Zhao et al., 2008; Zhou et al., 
2008). IP3R2 also contributes to acetylcholine-induced 
Type 1 IP3 receptors activate BKCa channels via local molecular coupling 
in arterial smooth muscle cells
Guiling Zhao,
1 Zachary P. Neeb,






2 and Jonathan H. Jaggar
1
1Department of Physiology, University of Tennessee Health Science Center, Memphis, TN 38163
2Department of Medicine, University of California, San Diego, La Jolla, CA 92093
Plasma membrane large-conductance Ca
2+-activated K
+ (BKCa) channels and sarcoplasmic reticulum inositol 1,4,5-
trisphosphate (IP3) receptors (IP3Rs) are expressed in a wide variety of cell types, including arterial smooth muscle 
cells. Here, we studied BKCa channel regulation by IP3 and IP3Rs in rat and mouse cerebral artery smooth muscle 
cells. IP3 activated BKCa channels both in intact cells and in excised inside-out membrane patches. IP3 caused con-
centration-dependent BKCa channel activation with an apparent dissociation constant (Kd) of 4 µM at physiologi-
cal voltage (40 mV) and intracellular Ca
2+ concentration ([Ca
2+]i; 10 µM). IP3 also caused a leftward-shift in BKCa 
channel apparent Ca
2+ sensitivity and reduced the Kd for free [Ca
2+]i from 20 to 12 µM, but did not alter the slope 
or maximal Po. BAPTA, a fast Ca
2+ buffer, or an elevation in extracellular Ca
2+ concentration did not alter IP3-in-
duced BKCa channel activation. Heparin, an IP3R inhibitor, and a monoclonal type 1 IP3R (IP3R1) antibody blocked 
IP3-induced BKCa channel activation. Adenophostin A, an IP3R agonist, also activated BKCa channels. IP3 activated 
BKCa channels in inside-out patches from wild-type (IP3R1
+/+) mouse arterial smooth muscle cells, but had no effect 
on BKCa channels of IP3R1-deficient (IP3R1
/) mice. Immunofluorescence resonance energy transfer microscopy 
indicated that IP3R1 is located in close spatial proximity to BKCa  subunits. The IP3R1 monoclonal antibody coim-
munoprecipitated IP3R1 and BKCa channel  and 1 subunits from cerebral arteries. In summary, data indicate 
that IP3R1 activation elevates BKCa channel apparent Ca
2+ sensitivity through local molecular coupling in arterial 
smooth muscle cells.
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0.023 EDTA, and 11 glucose. Posterior cerebral and cerebellar 
arteries (50–200 µm in diameter) were dissected from the brains 
and cleaned of connective tissue. Arterial smooth muscle cells 
were enzymatically dissociated from cerebral arteries as described 
previously, maintained at 4°C, and used within 8 h (Cheranov   
and Jaggar, 2006). Mouse aorta was used only for Western blot-
ting experiments.
Patch clamp electrophysiology
Single BKCa channel currents were recorded in isolated cerebral 
artery smooth muscle cells using either the cell-attached or inside-
out patch clamp configuration (Axopatch 200B and Clampex 8.2; 
MDS Analytical Technologies). For cell-attached patch, the pi-
pette and bath solution contained (in mM): 130 KCl, 10 HEPES, 
1 MgCl2, 5 EGTA, 1.6 HEDTA, and 10 µM free Ca
2+, pH 7.2 with 
KOH. For inside-out patches, the same pipette and bath solutions 
were used, except for experiments measuring BKCa channel Ca
2+ 
sensitivity, where free Ca
2+ concentration was adjﾭusted to between 
1 and 300 µM by the addition of CaCl2 and free Mg
2+ maintained 
at 1 mM by adjﾭustment of MgCl2. Where indicated, equimolar 
EGTA was substituted for BAPTA, a fast Ca
2+ chelator, in both the 
pipette and bath solutions. Free Ca
2+ concentration in solutions 
was measured using a Ca
2+-sensitive (no. 476041; Corning) and 
reference (no. 476370; Corning) electrode. Cell-attached and   
inside-out patch experiments were performed at membrane volt-
ages of +60 and 40 mV, respectively. BKCa currents were filtered 
at 1 kHz and digitized at 5 kHz. Analysis was performed offline   
using Clampfit 9.2 (MDS Analytical Technologies).
Western blotting
Mouse aorta or rat cerebral artery proteins were separated using 
7.5% SDS-polyacrylamide gels and transferred onto nitrocellulose 
membranes. Membranes were cut so that the same lysate could be 
probed  for  several  different  molecular  weight  proteins.  Mem-
branes  were  incubated  with  mouse  monoclonal  anti-IP3R1   
(NeuroMab), mouse monoclonal anti–BKCa  (NeuroMab), or rab-
bit  polyclonal  anti–BKCa  1  (Abcam)  primary  antibodies  over-
night  at  4°C  in  Tris-buffered  solution  (TBS)  containing  0.1% 
Tween 20 (TBS-T) and 5% nonfat dry milk. After washing with 
TBS-T, membranes were incubated with horseradish peroxidase–
conjﾭugated  secondary  antibodies,  followed  by  washing  with   
TBS-T. Membranes were then developed using enhanced chemi-
luminescence (GE Healthcare), and digital images were obtained 
using a Kodak FX Pro imaging system.
Immunofluorescence resonance energy transfer  
(immuno-FRET)
Isolated cells were allowed to adhere to poly-L-lysine–coated 
coverslips. Cells were then fixed with 3.7% paraformaldehyde, 
permeabilized with 0.1% Triton X-100, and treated with the   
following  primary  antibodies:  mouse  monoclonal  anti-IP3R1 
(clone L24/18; NeuroMab) and either rabbit polyclonal anti-
BKCa  (Abcam)  or  rabbit  polyclonal  anti-TRPM4  (Thermo 
Fisher Scientific), each at a dilution of 1:100. After washing, 
cells were incubated with the following secondary antibodies: 
Cy3-conjﾭugated donkey anti–mouse for IP3R1 (Jackson Immuno-
Research  Laboratories,  Inc.)  and  Cy2-conjﾭugated  goat  anti– 
rabbit (Jackson ImmunoResearch Laboratories, Inc.) for BKCa 
or TRPM4. After washing, coverslips were dried and mounted 
onto glass slides. Fluorescence images were acquired using a   
laser-scanning  confocal  microscope  (LSM  Pascal;  Carl  Zeiss, 
Inc.). Cy2 and Cy3 were excited at 488 and 543 nm, and emis-
sion was collected at 505–530 and ≥560 nm, respectively. Nega-
tive  controls  were  prepared  by  omitting  primary  antibodies. 
Images  were  background-subtracted,  and  N-FRET  was  calcu-
lated on a pixel-by-pixel basis for the entire image and in re-
gions of interest (within the boundaries of the cell) using the 
Ca
2+ oscillations in cultured portal vein smooth muscle 
cells (Morel et al., 2003). IP3R1 activation stimulates 
propagating intracellular Ca
2+ waves and causes an in-
crease in global [Ca
2+]i (Zhao et al., 2008). IP3R1 activa-
tion also stimulates a nonselective cation current (ICat) 
via an SR Ca
2+ release–independent mechanism in cere-
bral artery smooth muscle cells (Xi et al., 2008; Zhao   
et al., 2008). This cation current occurs due to physical 
coupling of IP3R1 to TRPC3 channels, is primarily due 
to Na
+ influx, and leads to membrane depolarization, 
voltage-dependent Ca
2+ channel activation, and a global 
[Ca
2+]i elevation (Xi et al., 2008; Adebiyi et al., 2010). 
IP3R1-mediated  SR  Ca
2+  release  and  TRPC3  channel   
activation both elevate [Ca
2+]i, leading to vasoconstriction 
(Xi et al., 2008; Zhao et al., 2008).
IP3R-mediated SR Ca
2+ release activates BKCa channels 
in basilar artery smooth muscle cells (Kim et al., 1998). 
Given that IP3Rs directly activate nearby TRPC3 chan-
nels  in  arterial  smooth  muscle  cells  (Xi  et  al.,  2008; 
Zhao et al., 2008; Adebiyi et al., 2010), we studied the 
mechanisms by which IP3 and IP3Rs modulate BKCa 
channels. We tested the hypothesis that IP3 activates 
BKCa  channels  via  an  SR  Ca
2+  release–independent 
mechanism. Our data indicate that IP3 activates BKCa 
channels both in intact cells and excised membrane 
patches where SR Ca
2+ release cannot occur. IP3 elevated 
BKCa channel apparent Ca
2+ sensitivity, required IP3R1 
activation, and was absent in IP3R1-deficient (IP3R1
/) 
cells.  Our  data  also  indicate  that  IP3R1  is  located  in 
close spatial proximity to BKCa channels and coimmu-
noprecipitates with BKCa channel  and 1 subunits. 
This  study  identifies  a  novel  signaling  mechanism 
whereby IP3R1 activation stimulates nearby BKCa chan-
nels.  Since  IP3Rs  and  BKCa  channels  are  broadly  ex-
pressed, this coupling mechanism may exist in a wide 
variety of different cell types.
M AT E R I A L S   A N D   M E T H O D S
Tissue preparation and cell isolation
All animal protocols were reviewed and approved by the University 
of Tennessee Animal Care and Use Committee. Male Sprague-
Dawley rats (6–8 wk) and wild-type and IP3R1
/ mice (3 wk) were 
euthanized  by  intraperitoneal  injﾭection  of  150  mg/kg  sodium   
pentobarbital.  Generation  of  the  IP3R1  knockout  mice  will  be   
described in a future publication. In brief, exon 5 of IP3R1 was 
flanked by two lox P sites, and IP3R1-floxed mice were generated 
by homologous recombination. IP3R1-floxed mice were subse-
quently crossed with protamine Cre mice (O’Gorman et al., 1997) 
to generate conventional IP3R1 knockout mice in which exon 5 is 
deleted globally and no IP3R1 protein can be detected (see Fig. 5 A). 
The phenotype of the global knockout IP3R1 mice generated   
is the same as that previously published for global loss of function 
of IP3R1 mice (Matsumoto et al., 1996). Brains were removed after 
the rats and mice were euthanized. Aorta was also collected from 
mice. Tissues were placed into ice-cold (4°C), oxygenated (21% O2, 
5% CO2), physiological saline solution containing (in mM):   
119 NaCl, 4.7 KCl, 24 NaHCO3, 1.2 KH2PO4, 1.6 CaCl2, 1.2 MgSO4,   Zhao et al. 285
bath solution at the end of each experiment. BKCa channel IP3 
sensitivity data and relationships between BKCa channel open prob-
ability (Po) and free Ca
2+ concentration were fit with a Boltzmann 
function: Y = Pomin + [(PomaxPomin)/(1+exp[(Kd-X)/slope])]. 
Values are expressed as mean ± SE. Student’s t test and repeated 
measures  analysis  of  variance  with  Student-Newman-Keuls   
post-hoc  test  were  used  for  comparing  paired  or  unpaired   
data and multiple datasets, as appropriate. P < 0.05 was consid-
ered significant.
Online supplemental material
Data in Fig. S1 demonstrate that antigenic peptides abolish flu-
orescent labeling by BKCa channel  and TRPM4 channel anti-
bodies. Also shown are differential interference contrast images 
of the same cells imaged for fluorescence. Fig. S1 is available at 
http://www.jﾭgp.org/cgi/content/full/jﾭgp.201010453/DC1.
R E S U LT S
IP3 activates BKCa channels in cerebral artery smooth 
muscle cells
BKCa channel regulation by IP3 was first measured in in-
tact arterial smooth muscle cells using the cell-attached 
configuration of the patch clamp technique. Bt-IP3, a 
membrane-permeant IP3 analogue, at concentrations 
of 10 and 50 µM, increased mean BKCa channel activity 
Xia method (Xia and Liu, 2001) and LSM FRET Macro tool 
(v2.5; Carl Zeiss, Inc.).
Coimmunoprecipitation (coIP)
Arterial  lysate  was  harvested  from  cerebral  arteries  pooled 
from 15 rats using ice-cold lysis buffer (Thermo Fisher Scien-
tific), giving 1.5 mg of total protein. coIP was done using the 
Thermo  Fisher  Scientific  Co-Immunoprecipitation  kit.  The 
IP3R1 antibody was first immobilized for 2 h using coupling 
resin (AminoLink Plus; Thermo Fisher Scientific). The resin 
was then washed and incubated with arterial lysate overnight. 
After incubation, the resin was again washed and protein was 
eluted  using  elution  buffer.  Non-denaturing  sample  buffer 
(Thermo Fisher Scientific) was added to the eluate and boiled. 
Negative controls received the same treatment, except that the 
coupling  resin  was  replaced  with  control  agarose  resin  that   
is  not  amine-reactive.  Samples  were  analyzed  using  Western 
blotting with mouse monoclonal anti-IP3R1, mouse monoclo-
nal  anti–BKCa  ,  or  rabbit  polyclonal  anti–BKCa  1  primary   
antibodies,  and  horseradish  peroxidase–conjﾭugated  second-
ary antibodies.
Statistical analysis
BKCa channel activity (NPo) was calculated from continuous gap-
free data using the following equation: NPo =  (t1 + t2...ti), where 
ti is the relative open time (time open/total time) for each chan-
nel level. Open probability (Po) was calculated by dividing NPo by 
channel number (N). The total number of channels in inside-out 
patches was determined by introducing 1 mM of free Ca
2+ into the 
Figure  1.  IP3  activates  BKCa 
channels  in  cerebral  artery 
smooth muscle cells. (A) Origi-
nal  recordings  obtained  from 
the same cell illustrating activa-
tion of BKCa channel by Bt-IP3 at 
+60 mV. (B) Mean data (n: con-
trol, 5; 10 µM Bt-IP3, 5; 50 µM   
Bt-IP3, 5). *, P < 0.05.
Figure 2.  IP3 activates BKCa channels in excised inside-out membrane patches. (A) Original recordings from the same inside-out   
patch illustrating concentration-dependent BKCa channel activation by IP3 at 40 mV. (B) Mean data fit with a Boltzmann function. 
IP3 increased BKCa channel Po with an apparent Kd of 4.1 ± 1.3 µM, a slope of 2.8 ± 1.9, and a maximal Po of 0.38 ± 0.02. Experimental   
numbers are ([IP3]): 0.01 µM, 4; 0.1 µM, 4; 1 µM, 4; 3 µM, 5; 10 µM, 5; 30 µM, 5. (C) Mean data illustrating that buffering Ca
2+ with BAPTA 
or elevating pipette (extracellular) Ca
2+ from 10 µM to 2 mM does not alter IP3 (10 µM)-induced BKCa channel activation (n: 10 µM   
[Ca
2+]o/10 µM [Ca
2+]i (EGTA/EGTA); control, 4; IP3, 4; 10 µM [Ca
2+]o/10 µM [Ca
2+]i (BAPTA/BAPTA); control, 4; IP3, 4; 2 mM 
[Ca
2+]o/10 µM [Ca
2+]i (none/EGTA) control, 3; IP3, 3). *, P < 0.05.286 IP3R1 activates BKCa channels
by IP3 increased considerably between 1 and 10 µM Ca
2+ 
(Fig. 3 B). For example, with 1 µM of free Ca
2+, IP3  
increased mean BKCa channel Po 1.14-fold, whereas with 
10  µM  of  free  Ca
2+,  IP3  increased  mean  Po  1.48-fold   
(Fig. 3 B). At free [Ca
2+] >10 µM, relative activation by 
IP3 became smaller because channel activity was ap-
proaching maximal. These data suggest that IP3 elevates 
BKCa channel apparent Ca
2+ sensitivity in arterial smooth 
muscle cells.
IP3R1 activation mediates IP3-induced BKCa  
channel activation
To  identify  mechanisms  by  which  IP3  activates  BKCa 
channels, we tested the hypothesis that IP3Rs mediate 
IP3-induced  BKCa  channel  activation.  In  inside-out 
patches, 1 mg/ml heparin, an IP3R blocker, reversed 
BKCa channel activation by IP3 (Fig. 4 A). In contrast,   
1 mg/ml heparin alone did not alter mean BKCa channel 
Po (98.9 ± 12.5% of control; n = 5; P > 0.05). These data 
indicate  that  IP3-induced  IP3R  activation  stimulates 
BKCa channels.
Type 1 IP3Rs are the principal molecular isoform ex-
pressed in cerebral artery and aortic smooth muscle cells 
(Zhao et al., 2008; Zhou et al., 2008; Adebiyi et al., 2010). 
Therefore, we studied whether IP3R1 mediates IP3- 
induced BKCa channel activation. In inside-out patches, 
a  monoclonal  IP3R1  antibody  (1:100)  reversed  IP3- 
induced BKCa channel activation (Fig. 4, B and C). In 
contrast, the IP3R1 antibody (1:100) did not alter mean 
BKCa channel activity when applied alone (94.2 ± 4.9% 
of control; n = 4; P > 0.05). The addition of heparin in 
the presence of IP3 plus IP3R1 antibody did not cause 
any further reduction in BKCa channel Po (Fig. 4, B and C). 
Boiled (95°C for 15 min) IP3R1 antibody did not alter 
IP3-induced BKCa channel activation (Fig. 4 C). To fur-
ther examine BKCa channel regulation by IP3Rs, we used 
adenophostin A as an alternate IP3R agonist. 1 µM   
adenophostin A increased BKCa channel activity 1.60-
fold (Fig. 4 D). These data indicate that IP3R1 activation 
is necessary for IP3-mediated BKCa channel activation in 
arterial smooth muscle cells.
(NPo) 1.8- and 1.9-fold, respectively, at +60 mV (Fig. 1, 
A and B).
Next, we investigated whether IP3 has effects on BKCa 
channels  that  are  independent  of  plasma  membrane 
Ca
2+ influx or intracellular Ca
2+ release. BKCa channel 
regulation was studied in excised inside-out membrane 
patches at a physiological steady membrane voltage of 
40 mV, which is similar to that of cerebral arteries pres-
surized to 60 mmHg (Knot and Nelson, 1998). In inside-
out patches exposed to symmetrical 10 µM of free [Ca
2+]i, 
10 µM IP3 increased mean BKCa channel open probabil-
ity (Po) from 0.24 to 0.37, or 1.54-fold (Fig. 2, A and B). 
In contrast, IP3 did not alter single BKCa channel ampli-
tude (pA: control, 8.5 ± 0.47; IP3, 8.0 ± 0.36; n = 5; P > 0.05; 
Fig. 2 A). IP3 also caused concentration-dependent BKCa 
channel activation (Fig. 2 B). Fitting an IP3 concentra-
tion–response curve with a Boltzmann function indi-
cated that IP3 increased BKCa channel Po with an apparent 
Kd of 4.1 µM, a slope of 2.8, and a maximal Po of 
0.38 (Fig. 2 B). IP3 activated BKCa channels in excised 
patches for as long as the seal could be maintained   
(>30 min), indicating that SR Ca
2+ release was unlikely 
to be responsible for channel activation. In support of 
this concept, equimolar substitution of bath and pipette 
EGTA for BAPTA, a fast Ca
2+ chelator, did not alter IP3-
induced BKCa channel activation (Fig. 2 C). Elevating pi-
pette free Ca
2+ from 10 µM to 2 mM also did not alter 
IP3-induced  BKCa  channel  activation,  indicating  that 
plasma membrane Ca
2+ influx was not responsible for 
channel activation (Fig. 2 C). Collectively, these data   
indicate that IP3 activates BKCa channels via an SR Ca
2+ 
release–independent mechanism.
IP3 elevates BKCa channel apparent Ca
2+ sensitivity
IP3 regulation of BKCa channel apparent Ca
2+ sensitivity 
was examined at a steady membrane voltage of 40 mV. 
In control, mean apparent Kd for Ca
2+ was 20 µM, with 
a slope of 1.2, and a maximum Po of 0.82 (Fig. 3 A). 
In the same membrane patches, 10 µM IP3 decreased 
the mean Kd for Ca
2+ to 12 µM, but did not alter the 
slope or the maximum Po (Fig. 3 A). Relative activation 
Figure  3.  IP3  elevates  BKCa 
channel  apparent  Ca
2+  sensitiv-
ity.  (A)  Mean  data  illustrating 
IP3-induced  BKCa  channel  acti-
vation over a range of free Ca
2+ 
concentrations  in  inside-out 
patches at 40 mV. Data are fit 
with a Boltzmann function con-
strained  to  ≥0.  Experimental 
numbers  are  given  after  each 
[Ca
2+] (µM): control: 1, 8; 3, 6; 
10, 6; 30, 6; 100, 8; 300, 8; 10 µM 
IP3: 1, 7; 3, 6; 10, 6; 30, 6; 100, 7; 
300, 7. (B) Mean data illustrating IP3-induced change in BKCa channel Po at each [Ca
2+]. Data are fit with a Gaussian function. In control, 
the Kd for Ca
2+ was 20.4 ± 0.9 µM, a slope of 1.2 ± 0.2, and a maximum Po of 0.82 ± 0.04. 10 µM IP3 decreased the mean Kd for Ca
2+ to   
12.4 ± 0.8 µM (P < 0.05), but did not alter the slope (1.3 ± 0.3) or the maximum Po (0.83 ± 0.03; P > 0.05 for each).  Zhao et al. 287
BKCa channel  subunits colocalize with IP3R1
Our data indicate that IP3R1 and BKCa channels func-
tionally interact. Therefore, spatial localization of these 
proteins was studied using immuno-FRET microscopy. 
Cy2- and Cy3-tagged secondary antibodies targeting pri-
mary antibodies bound to IP3R1 and BKCa channel  sub-
units, respectively, generated whole cell N-FRET of 20.4 ± 
1.3% (n = 11; Fig. 6 A). In contrast, whole cell N-FRET 
between IP3R1 and TRPM4 channels, which do not colo-
calize in cerebral artery smooth muscle cells (Adebiyi   
et al., 2010), was significantly lower at 7.4 ± 1.0% (n = 10; 
P > 0.05; Fig. 6 A). N-FRET between IP3R1 and BKCa chan-
nels was observed both at the plasma membrane and in-
tracellularly.  Antigenic  peptides  abolished  fluorescent 
labeling by BKCa and TRPM4 channel antibodies, respec-
tively (Fig. S1). An antigenic peptide was not available 
for the monoclonal IP3R1 antibody, but this antibody de-
tects only IP3R1 protein in a Western blot, indicating se-
lectivity (Adebiyi et al., 2010). These data indicate that 
IP3R1 is located in close proximity to plasma membrane 
BKCa channels in arterial smooth muscle cells.
To further investigate the necessity for IP3R1 and to   
determine whether IP3-induced BKCa channel activation 
occurs in another species, we studied BKCa channel 
regulation in mouse wild-type (IP3R1
+/+) and IP3R1 
knockout (IP3R1
/) cerebral artery smooth muscle cells. 
Western blotting confirmed that IP3R1 was present in 
IP3R1
+/+ mouse aorta, but absent in IP3R1
/ mouse   
aorta (Fig. 5 A). BKCa channel Po (IP3R1
+/+, 0.30 ± 0.08; 
IP3R1
/, 0.27 ± 0.03; n = 5) and amplitude (pA: IP3R1
+/+, 
10.2 ± 0.8; IP3R1
/, 11.4 ± 0.8; n = 5) were similar in   
inside-out patches from IP3R1
+/+ and IP3R1
/ cerebral 
artery smooth muscle cells exposed to 10 µM Ca
2+ (P > 0.05   
for each). IP3 increased mean BKCa channel Po to 142% 
of control in inside-out patches from mouse IP3R1
+/+ cells 
(Fig. 5 B). Furthermore, in patches from IP3R1
+/+ cells, 
IP3-induced BKCa channel activation was reversed by hep-
arin (Fig. 5 B). In contrast, IP3 or IP3 plus heparin did not 
alter BKCa channel Po in excised patches from IP3R1
/ 
arterial smooth muscle cells (Fig. 5 B). These data indi-
cate that IP3R1 is essential for IP3-induced BKCa channel 
activation in cerebral artery smooth muscle cells.
Figure 4.  IP3R1 mediates IP3-induced BKCa channel activation. (A) Mean data illustrating that heparin reverses IP3-induced BKCa chan-
nel activation (n: control (10 µM Ca
2+), 5; 30 µM IP3, 5; 30 µM IP3 plus 1 mg/ml heparin, 5). (B) Original recording from the same 
inside-out patch illustrating control BKCa channel activity (i), IP3 (30 µM)-induced channel activation (ii), reversal by monoclonal IP3R1 
antibody (iii, 1:100; clone L24/18; NeuroMab), and no further effect of heparin applied in the continued presence of IP3R1 antibody (iv).   
(C) Mean data illustrating that monoclonal IP3R1 antibody inhibits IP3-induced BKCa channel activation, and that the addition of hepa-
rin leads to no further change in activity (control (10 µM Ca
2+), n = 4; 30 µM IP3, n = 4; 30 µM IP3 plus IP3R1 antibody (1:100), n = 4; 
30 µM IP3 plus IP3R1 antibody (1:100), n = 4; 30 µM IP3 plus IP3R1 antibody (1:100) plus heparin, n = 4; IP3 plus boiled IP3R1 antibody, 
n = 4). (D) Mean data illustrating that adenophostin A activates BKCa channels (n: control (10 µM Ca
2+), 4; 1 µM adenophostin A, 4).   
*, P < 0.05.288 IP3R1 activates BKCa channels
mechanism whereby IP3R1 channels activate plasma 
membrane BKCa channels via an SR Ca
2+ release–inde-
pendent local coupling mechanism in arterial smooth 
muscle cells. Given that both IP3Rs and KCa channels   
are widely expressed, such communication may occur 
in other cell types.
Agonist binding to PLC-coupled receptors leads to 
phosphatidylinositol 4,5-bisphosphate cleavage and an 
elevation in both diacyglycerol and IP3 in smooth mus-
cle cells. Diacyglycerol remains membrane bound and 
stimulates PKC, which phosphorylates a wide variety of 
target proteins that regulate contractility, including ion 
channels and the contractile apparatus (Davis and Hill, 
1999; Jaggar et al., 2000). Relevant to this study, PKC in-
hibits arterial smooth muscle cell BKCa channels, lead-
ing to membrane depolarization and vasoconstriction 
(Davis and Hill, 1999; Jaggar et al., 2000). Arteries un-
dergo steady-state changes in membrane potential, with 
a dynamic range between 60 and 20 mV (Knot 
and Nelson, 1998; Davis and Hill, 1999). Here, BKCa 
channel  regulation  was  studied  primarily  at  a  steady 
voltage of 40 mV, which is the membrane potential of 
cerebral arteries at a physiological intravascular pres-
sure of 60 mmHg (Knot and Nelson, 1998). IP3 acti-
vated BKCa channels in both intact cells and in excised 
membrane patches. In excised patches, IP3 increased 
BKCa channel activity with an apparent Kd of 4 µM. 
Previous studies have estimated global intracellular IP3 
concentration ([IP3]i) to be 0.1–3 µM in unstimulated 
cells and 1–20 µM in agonist-stimulated cells (Finch and 
Augustine, 1998; Luzzi et al., 1998; Takechi et al., 1998; 
Patel et al., 1999). Recent studies using fluorescent IP3 
biosensors  suggested  that  receptor  agonists  elevate 
global [IP3]i to 30 nM in cardiac myocytes and up to 
700 nM in COS-7 and HSY-EA1 cells (Remus et al., 2006; 
Tanimura et al., 2009). In arterial myocytes, global [IP3]i 
is unclear, but local IP3 gradients higher than global 
[IP3]i should exist, particularly within the immediate vi-
cinity of PLC where IP3 is generated. The [IP3]i nearby 
a target protein such as an IP3R will depend on many 
factors,  including  PLC  activity,  proximity  of  IP3Rs  to 
PLC, and IP3 metabolism. KCa channel IP3 sensitivity de-
termined  here  may  indicate  IP3  concentrations  that 
would occur nearby IP3Rs that are located in close prox-
imity to plasma membrane BKCa channels.
IP3 acts primarily by relieving Ca
2+ inhibition of IP3Rs, 
thereby  permitting  Ca
2+-induced  channel  activation 
(Thrower et al., 2001; Foskett et al., 2007). Physiological 
micromolar [Ca
2+]i concentrations used here to study 
KCa channel activity would be expected to attenuate IP3-
induced IP3R activation and may provide one explana-
tion for the micromolar IP3 sensitivity of BKCa channel 
activation.  IP3R  IP3  sensitivity  can  also  vary  widely 
from nanomolar to micromolar depending on multiple   
factors in addition to [Ca
2+]i, including IP3R isoform, 
splice variation, which can occur in many regions of the 
BKCa channel  and 1 subunits coimmunoprecipitate  
with IP3R1
coIP was performed to test the hypothesis that IP3R1 
and BKCa channels are contained within the same macro-
molecular protein complex. Due to the small size of   
the resistance (100–200-µm diameter), cerebral arteries 
used in this study, arteries collected from 15 rats, were 
required for each coIP experiment. The monoclonal 
IP3R1 antibody coimmunoprecipitated IP3R1 with BKCa 
channel  and 1 subunits from cerebral artery lysate 
(Fig.  6  B).  These  data  indicate  that  IP3R1  and  BKCa 
channels are located within the same macromolecular 
complex in arterial smooth muscle cells.
D I S C U S S I O N
Here, we demonstrate that IP3-induced IP3R1 activation 
stimulates BKCa channels via a local SR Ca
2+ release– 
independent coupling mechanism in cerebral artery 
smooth muscle cells. Novel findings are that: (a) IP3 ac-
tivates BKCa channels in excised membrane patches re-
moved from cytosolic signaling pathways; (b) IP3 elevates 
BKCa channel apparent Ca
2+ sensitivity; (c) IP3R1 expres-
sion  and  activation  are  required  for  IP3  to  stimulate 
BKCa channels; and (d) IP3R1 and BKCa channel sub-
units are located in close spatial proximity and coimmu-
noprecipitate. These data identify a novel signaling 
Figure  5.  Genetic  ablation  of  IP3R1  abolishes  IP3-induced 
BKCa channel activation in cerebral artery smooth muscle cells. 
(A) Western blot indicating that IP3R1 protein (270 kD) is pres-
ent in IP3R1
+/+ mouse aorta and absent in IP3R1
/ aorta. (B) Mean 
data illustrating that 10 µM IP3 activates BKCa channels in inside-
out patches from mouse IP3R1
+/+ cerebral artery smooth muscle 
cells, but not in mouse IP3R1
/ cerebral artery smooth muscle 
cells. Mean data also indicate that 1 mg/ml heparin reverses IP3-
induced  BKCa  channel  activation  in  IP3R1
+/+  cells.  Membrane 
voltage was 40 mV. IP3R1
/: control, n = 5; IP3, n = 5; IP3 plus 
heparin, n = 5. IP3R1
+/+: control, n = 5; IP3, n = 5; IP3 plus heparin, 
n = 5. *, P < 0.05.  Zhao et al. 289
macromolecular complex. In contrast to FRET data in-
dicating close spatial proximity of IP3R1 and BKCa chan-
nels,  immuno-FRET  data  indicated  that  IP3R1  and 
TRPM4 channels are not spatially localized in arterial 
smooth muscle cells, in agreement with a recent report 
(Adebiyi et al., 2010). BKCa channels are also located 
nearby IP3Rs in cultured glioma cells, but in contrast to 
the observations made here, glioma cell IP3Rs activate 
BKCa channels via Ca
2+ signaling and direct molecular 
coupling is absent (Weaver et al., 2007). Electron mi-
croscopy studies have shown that the SR and plasma 
membranes  can  be  located  in  very  close  proximity 
(20  nm)  in  arterial  smooth  muscle  cells  (Devine   
et al., 1972). Conceivably, IP3R1 and BKCa channels may 
be  present  within  macromolecular  complexes  that 
bridge the SR and plasma membranes, allowing local 
molecular  communication  between  these  proteins.   
Immuno-FRET between IP3R1 and BKCa channel  sub-
units was observed both at the plasma membrane and 
intracellularly. The physiological function of close lo-
calization between IP3R1 and intracellular BKCa chan-
nels  is  unclear.  Conceivably,  BKCa  channels  may  be 
contained within the SR or Golgi before membrane 
trafficking, and intracellular FRET may reflect the close 
proximity of these intracellular BKCa channels to IP3R1 
located on the SR membrane. Alternatively, IP3R1 and 
BKCa channels may form into a protein complex before 
membrane trafficking.
Intact SR may have been excised within membrane 
patches, although SR Ca
2+ would be depleted due to the 
recording conditions used (no ATP in bath solution). 
protein including the IP3-binding domain, and poten-
tially through isoform heterotetramerization (Thrower 
et al., 2001; Foskett et al., 2007). For example, canine 
cerebellar IP3R1 is sensitive to IP3 over a broad concen-
tration range and exhibits high (nM) and low (10 µM) 
affinity IP3-binding sites. The IP3 and Ca
2+ sensitivity of 
arterial smooth muscle cell IP3Rs has not been deter-
mined, nor have these channels been cloned. Therefore, 
deriving  mechanistic  details  regarding  IP3R  com-
munication with KCa channels is difficult until detailed 
knowledge of smooth muscle cell IP3Rs is available, 
particularly IP3 and Ca
2+ sensitivity. Our data indicate 
that  under  physiological  voltage  and  local  [Ca
2+]i,   
micromolar  [IP3]i  is  required  for  IP3Rs  to  activate 
BKCa channels.
Data indicate that IP3 does not directly activate BKCa 
channels.  Rather,  IP3R1  mediates  IP3-induced  BKCa 
channel activation. This conclusion is supported by our 
observation that heparin, an IP3R1 antibody, and IP3R1 
ablation all blocked IP3-induced BKCa channel activa-
tion.  These  data  also  indicate  that  functional  IP3R1 
protein is excised together with BKCa channels in in-
side-out patches. The Förster distance between Cy2 
and Cy3 is 5–6 nm. If Cy2 and Cy3 are located in such 
local  proximity,  nonradiative  dipole–dipole  coupling 
between excited Cy2 (donor) and Cy3 (acceptor) leads 
to Cy3 emission. Thus, for FRET to occur, IP3R1 must 
be located in very close spatial proximity to BKCa chan-
nels.  Supporting  local  interaction  between  these   
proteins,  coIP  data  indicated  that  IP3R1  and  BKCa 
channel  and 1 subunits were located in the same 
Figure 6.  BKCa channel subunits are located in 
close spatial proximity to IP3R1 in cerebral artery 
smooth  muscle  cells.  (A)  Immuno-FRET  data   
illustrating  close  spatial  proximity  of  IP3R1  to 
BKCa channel  subunits. Cy2- and Cy3-labeled 
secondary antibodies bound to IP3R1 and BKCa 
channels generate N-FRET. In contrast, second-
ary antibodies bound to IP3R1 and TRPM4 do   
not  generate  significant  N-FRET.  Bars,  10  µm. 
(B)  Monoclonal  IP3R1  antibody  coimmuno-
precipitates  IP3R1  (270  kD),  BKCa  channel 
 (125 kD), and 1 (36 kD) subunits from 
cerebral arteries. Lysate supernatant was used as 
the input (+ve) control. Beads that have no anti-
body-binding capacity were used in the negative 
(ve) coIP control.290 IP3R1 activates BKCa channels
vasoconstrictors  also  activate  Ca
2+  waves  and  elevate 
global [Ca
2+]i (Jaggar and Nelson, 2000; Mauban et al., 
2001; Zhao et al., 2008; Adebiyi et al., 2010). IP3R1 acti-
vation is essential for vasoconstrictor-induced Ca
2+ waves 
and contributes to the global [Ca
2+]i elevation (Zhao   
et al., 2008). Collectively, these studies suggest that PLC-
coupled receptor agonists shift control of BKCa channel 
activity from RYR channels to IP3Rs. IP3-induced BKCa 
channel activation would limit PKC-induced BKCa chan-
nel inhibition and attenuate the membrane depolariza-
tion and vasoconstriction.
The  signaling  mechanism  by  which  IP3R1  elevates 
BKCa channel apparent Ca
2+ sensitivity was not studied 
here. Several possibilities exist, including that an IP3- 
induced conformational change in IP3R1 may lead to di-
rect interaction with either the BKCa channel  and/or 
1 subunit. IP3R1 may also activate BKCa channels via an 
indirect interaction through intermediate proteins, 
including caveolin-1 (Cheng and Jaggar, 2006; Alioua   
et al., 2008). A deeper understanding of the molecular 
mechanisms by which IP3Rs stimulate BKCa channels will 
require further investigation.
In  summary,  data  indicate  that  IP3-induced  IP3R1   
activation elevates BKCa channel apparent Ca
2+ sensitiv-
ity through localized molecular coupling in arterial 
smooth  muscle  cells.  This  negative  feedback  mecha-
nism would limit IP3-induced vasoconstriction in cere-
bral arteries. These data also raise the possibility that 
local communication between IP3Rs and BKCa channels 
may occur in a wide variety of cell types that express 
both of these proteins.
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